美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Lakewood-Amedex Biotherapeutics (Direct Listing)

0.9502

-0.5498-36.65%

盤前：0.8000-0.1502-15.81%07:44 EDT

成交量：3,788.04萬

成交額：8,710.66萬

市值：1,360.72萬

市盈率：-3.47

高：1.47

開：1.35

低：0.9200

收：1.50

52周最高：9.82

52周最低：0.9200

股本：1,432.04萬

流通股本：470.00萬

量比：167.62

換手率：805.97%

股息：- -

股息率：- -

每股收益(TTM):-0.2740

淨資產收益率：--

總資產收益率：-303.80%

市淨率：-6.92

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Lakewood-Amedex Biotherapeutics (Direct Listing)

交易所：

NASDAQ

成立時間：

2006

員工人數：

5

公司地址：

8031 Cooper Creek Blvd.,Suite 103,University Park,Florida,United States

官網：

http://lakewoodamedex.com

郵編：

34201

電話：

傳真：

- -

簡介：

Lakewood-Amedex Biotherapeutics Inc.最初於2006年7月11日在特拉華州註冊成立。該公司是一家私營製藥公司，專註於通過開發其雙磷酸黴素來應對抗菌素耐藥性（AMR）的全球健康危機類抗菌劑。該公司的方法涉及一種新機制，旨在迅速破壞細菌膜的穩定性，這可能會降低耐藥性發展的可能性。他們的先導化合物Nu-3目前正處於治療感染的糖尿病足潰瘍的臨床試驗中，被配製為外用凝膠，可提供快速的抗菌作用和靶向遞送。除了糖尿病足潰瘍，該公司正在探索在治療複雜的尿路感染和肺部感染方面的應用。

董事

名稱

職位

Doug Manion

Chairman of the Board and Director

Kelvin Cooper

Chief Executive Officer,Director and SVP Research & Development

Joseph Tucker

Independent Director

Leonard J. DeRoma

Independent Director

股東

名稱

職位

Kelvin Cooper

Chief Executive Officer,Director and SVP Research & Development

Peter Ceccacci

Chief Financial Officer and VP Administration

Thomas Balzer

Chief Medical Officer and SVP Clinical Development

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/LABT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","market":"US","secType":"STK","nameCN":"Lakewood-Amedex Biotherapeutics (Direct Listing)","latestPrice":0.9502,"timestamp":1779134400000,"preClose":1.5,"halted":0,"volume":37880443,"hourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":0.9502,"latestTime":"07:44 EDT","volume":107651,"amount":89832.1974062,"timestamp":1779191079059,"change":-0.1502,"changeRate":-0.158072,"amplitude":0.217428},"delay":0,"changeRate":-0.3665333333333333,"floatShares":4700000,"shares":14320400,"eps":-0.274,"marketStatus":"盤前交易","change":-0.5498,"latestTime":"05-19 07:44:50 EDT","open":1.35,"high":1.47,"low":0.92,"amount":87106627.94492349,"amplitude":0.366667,"askPrice":0.85,"askSize":300,"bidPrice":0.782,"bidSize":262,"shortable":0,"etf":0,"ttmEps":-0.274,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1779197400000},"marketStatusCode":1,"adr":0,"listingDate":1776916800000,"exchange":"NASDAQ","adjPreClose":0.9502,"preHourTrading":{"tag":"盘前","latestPrice":0.8,"preClose":0.9502,"latestTime":"07:44 EDT","volume":107651,"amount":89832.1974062,"timestamp":1779191079059,"change":-0.1502,"changeRate":-0.158072,"amplitude":0.217428},"postHourTrading":{"tag":"盘后","latestPrice":0.8911,"preClose":0.9502,"latestTime":"19:59 EDT","volume":744205,"amount":666843.821107,"timestamp":1779148782671,"change":-0.0591,"changeRate":-0.062197,"amplitude":0.131446},"volumeRatio":167.61678151384643},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABT\",,,,,undefined,":{"symbol":"LABT","floatShares":4700000,"roa":"-303.80%","roe":"--","lyrEps":0,"volumeRatio":167.61678151384643,"shares":14320400,"dividePrice":0,"high":1.47,"amplitude":0.366667,"preClose":1.5,"low":0.92,"week52Low":0.92,"pbRate":"-6.92","week52High":9.82,"institutionHeld":0,"latestPrice":0.9502,"committee":-0.067616,"eps":-0.274,"divideRate":0,"volume":37880443,"delay":0,"ttmEps":-0.274,"open":1.35,"prevYearClose":8,"prevWeekClose":1.5,"prevMonthClose":2.66,"prevQuarterClose":8,"fiveDayClose":3.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LABT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LABT","date":"2026-05-15","current":-3.467883,"percent":1,"low":-12.282138,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"high":-7.294845,"avg":-11.240017,"sd":1.440936,"marketCap":28067917},"quantilePoints":[{"date":"2026-05-08","current":-12.282138,"twenty":-12.192813,"median":-11.891342,"eighty":-11.604759,"marketCap":47257207},{"date":"2026-05-15","current":-7.294845,"twenty":-12.043939,"median":-11.649421,"eighty":-11.314454,"marketCap":28067917}],"updateTime":1779168012652},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1977810588,"yearFounded":2006,"employeeNum":5,"address":"8031 Cooper Creek Blvd.,Suite 103,University Park,Florida,United States","zipCode":"34201","officePhone":"941 225 2515","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://lakewoodamedex.com","stockEarnings":[{"period":"1week","weight":-0.6993},{"period":"1month","weight":-0.8812},{"period":"ytd","weight":-0.8812}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Lakewood-Amedex Biotherapeutics Inc.最初於2006年7月11日在特拉華州註冊成立。該公司是一家私營製藥公司，專註於通過開發其雙磷酸黴素來應對抗菌素耐藥性（AMR）的全球健康危機類抗菌劑。該公司的方法涉及一種新機制，旨在迅速破壞細菌膜的穩定性，這可能會降低耐藥性發展的可能性。他們的先導化合物Nu-3目前正處於治療感染的糖尿病足潰瘍的臨床試驗中，被配製為外用凝膠，可提供快速的抗菌作用和靶向遞送。除了糖尿病足潰瘍，該公司正在探索在治療複雜的尿路感染和肺部感染方面的應用。","exchange":"NASDAQ","name":"Lakewood-Amedex Biotherapeutics (Direct Listing)","nameEN":"Lakewood-Amedex Biotherapeutics (Direct Listing)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"LABT\",market:\"US\",,,undefined,":{"directors":[{"name":"Doug Manion","position":"Chairman of the Board and Director"},{"name":"Kelvin Cooper","position":"Chief Executive Officer,Director and SVP Research & Development"},{"name":"Joseph Tucker","position":"Independent Director"},{"name":"Leonard J. DeRoma","position":"Independent Director"}],"executives":[{"name":"Kelvin Cooper","position":"Chief Executive Officer,Director and SVP Research & Development"},{"name":"Peter Ceccacci","position":"Chief Financial Officer and VP Administration"},{"name":"Thomas Balzer","position":"Chief Medical Officer and SVP Clinical Development"}]}}}